The Role of Ischaemic Heart Disease in Severe COVID-19 Outcomes Among Urban Residents of Uzbekistan: A Retrospective Study from a Single Center - Summary - MDSpire

The Role of Ischaemic Heart Disease in Severe COVID-19 Outcomes Among Urban Residents of Uzbekistan: A Retrospective Study from a Single Center

  • By

  • Nargiz Ibadullaeva

  • Erkin Musabaev

  • Aziza Khikmatullaeva

  • Leonid Padyukov

  • February 12, 2026

  • 0 min

Share

Objective:

To identify major clinical factors associated with severe versus mild/moderate COVID-19 in patients of Uzbek ethnicity, particularly focusing on the implications of ACE I/D and IL28B gene polymorphisms on disease outcomes.

Key Findings:
  • 227 patients were included, with 66 mild, 76 moderate, and 85 severe cases of COVID-19.
  • Significant associations were found between genetic polymorphisms and disease severity (p-values to be included).
  • ACE I/D and IL28B polymorphisms may influence COVID-19 outcomes in the Uzbek population.
Interpretation:

The study suggests that genetic factors, particularly ACE I/D and IL28B polymorphisms, are important in determining the severity of COVID-19 among Uzbek patients, which may inform treatment strategies.

Limitations:
  • Single-center study may limit generalizability.
  • Retrospective design may introduce biases.
  • Sample size may not be sufficient to draw definitive conclusions.
  • Potential confounding factors not addressed.
Conclusion:

Genetic polymorphisms could be significant predictors of COVID-19 severity, highlighting the need for personalized treatment approaches based on genetic risk factors.

Original Source(s)

Related Content